Abstract
Diabetes is well recognized as a major global health problem. The clinical manifestation and progression of diabetes often vary considerably between countries and commonly between ethnic groups in the same country. Currently diabetes affects an estimate 15.1 million people in North America, 12.6 million in Latin America, 18.5 million in Europe, 6.6 million in the former USSR, 5.3 million in Africa, 51.4 million in Asia, and just under 1 million in Oceania (McCarty and Zimmet 1994).
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
American Diabetes Association (ADA) (1993) Diabetes 1993 vital statistics. American Diabetes Association, Alexandria
Bailey CJ (1992) Biguanides and NIDDM. Diabetes Care 15:755–772
Blume H, Förster H, Stenzhorn G, Askali F (1985a) Zur Bioverfügbarkeit und pharmakodynamischen Aktivität hendelsüblicher Glibenclamid-Fertigarzneimittel, 2nd end. Pharm Ztg 130:1070–1078
Blume H, Ali SL, Stenzhorn G, Stüber W, Siewert M (1985b) Zur Bioverfügbarkeit und pharmakodynamischen Aktivität handelsüblicher Glibenclamid-Fertigarzneimittel, 3rd end. Pharm Ztg 130:2605–2610
Dunn CJ, Peters DG (1995) Metformin: a review of its pharmacological properties and therapeutic use in non-insulin-dependent diabetes mellitus. Drugs 49:721–749
Groop LC (1992) Sulfonylureas in NIDDM. Diabetes Care 15:737–754
Herman W, Sinnock P, Brenner E, Brimberry JL, Langford D, Nakashima A, Sepe SJ, Teutsch SM, Mazze RS (1984) An epidemiological model for diabetes mellitus: incidence, prevalence and mortality. Diabetes Care 7:367–371
Hermann LS, Melander A (1992) Biguanides: basic aspects and clinical uses. In: Alberti KGM, Defronzo RA, Keen H, Zimmet P (eds) International textbook of diabetes mellitus. Wiley, Chichester vol 28, pp 773–795
Mazze RS (1994) A systems approach to diabetes care. Diabetes Care 17:5–11
Mazze RS, Sinnock P, Deeb L, Brimberry J (1985) An epidemiological model for diabetes mellitus in the United States: five major complications. Diabetes Res Clin Pract 1:185–191
McCarty D, Zimmet P (1994) Diabetes 1994 to 2010: global estimates and projections. International Diabetes Institute, Melbourne
UK Prospective Diabetes Study (UKPDS) (1991) VIII. Study design, progress and performance. Diabetologia 34:877–890
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Kuhlmann, J. (1996). Introduction. In: Kuhlmann, J., Puls, W. (eds) Oral Antidiabetics. Handbook of Experimental Pharmacology, vol 119. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-09127-2_1
Download citation
DOI: https://doi.org/10.1007/978-3-662-09127-2_1
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-62456-1
Online ISBN: 978-3-662-09127-2
eBook Packages: Springer Book Archive